Antisauvagine-30 TFA (aSvg-30 TFA) is a potent, highly selective and competitive CRF 2 receptor peptidic antagonist. Antisauvagine-30 TFA exhibits a K d of 1.4 nM and 150 nM for mCRFR2β and CRFR1, respectively.
性状
Solid
IC50 & Target[1][2]
Kd: 1.4 nM (mCRFR2β), 150 nM (CRFR1).
体外研究(In Vitro)
Antisauvagine-30 (aSvg-30) prevents stress-enhanced fear conditioning and Mek-1/2-dependent activation of Erk-1/2 and p90Rsk-1. Antisauvagine-30 (aSvg-30) did not affect the phosphorylation of the PKA regulatory subunit II of stressed mice. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Antisauvagine-30 (aSvg-30; i.h. 400 ng/0.5 μl per mouse) selectively prevents the stress-induced enhancement of fear conditioning without affecting the fear conditioning of nonstressed mice.
Antisauvagine-30 (aSvg-30) injected i.c.v. elicits a significant anxiogenic effect. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Sealed storage, away from moisturePowder -80°C 2 years;-20°C 1 year
SequenceShortening
{D-Phe}-HLLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2
参考文献
[1]. Brauns O, et al. Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments. Neuropharmacology. 2001 Sep;41(4):507-16.[2]. Sananbenesi F, et al. Mitogen-activated protein kinase signaling in the hippocampus and its modulation by corticotropin-releasing factor receptor 2: a possible link between stress and fear memory. J Neurosci. 2003 Dec 10;23(36):11436-43.
溶解度数据
In Vitro: H2O : 25 mg/mL (6.64 mM; Need ultrasonic)配制储备液